Filing Flows

Filing Flows › 8-K events › Shuttle Pharmaceuticals Holdings

Shuttle Pharmaceuticals Holdings: change in the certifying accountant

Form 8-K filed Oct 22, 2026 · items 4.01

What the filing says

Dismissal of Independent Registered Public Accounting Firm. On October 16, 2026, the Audit Committee (the “Audit Committee”) of the Board of Directors (the “Board”) of Shuttle Pharmaceuticals Holdings, Inc. (the “Company”), and the full Board, approved the dismissal of Forvis Mazars, LLP (“Forvis Mazars”) as the Compan

Read the filing on SEC EDGAR →

What usually followsAcross 538 8-Ks reporting Item 4.01 (change in auditor) in our universe, the stock's median move the next session was 0.0% (typical size ±1.7%, up 49% of the time); over the following 21 sessions, −0.1%. Every item ranked →

What this kind of filing means

Item 4.01 — Change in the certifying accountant. A change of auditor is routine when cost-driven, a warning sign when it follows a disagreement — the filing must say which.

Shuttle Pharmaceuticals Holdings’s other material 8-Ks

Other recent auditor changes

Read automatically from SEC EDGAR (13F, Form 4, Form 144, Schedule 13D/G, 8-K, XBRL), House and Senate disclosures, FINRA and exchange data; errors are possible. Not investment advice.